The immuno-efficacy of the Hub genes was evaluated using multiple datasets from mRNA isolated from the peripheral whole blood of patients with RA undergoing different immunotherapy treatments, including anti-TNF antibodies, Rituximab, Infiximab, Methotrexate, and Abatacept. The gene discussed is TNF; the disease is rheumatoid arthritis.